Effexor Plaintiffs Want To Drop 40% Of Suits From MDL
By Sindhu Sundar (January 27, 2015, 9:33 PM EST) -- The plaintiffs in multidistrict litigation over Wyeth Pharmaceuticals Inc.'s depression and anxiety drug Effexor have sought to drop some 26 suits targeting the Pfizer unit over the drug's alleged birth defect risks, and a Pennsylvania federal judge has granted dismissals in at least eight of them.
U.S. District Judge Cynthia Rufe issued short orders on Friday signing off on at least eight stipulations by plaintiffs to drop the suits. There were a total of some 65 suits in the litigation before the dismissals. Plaintiffs on Tuesday filed four new stipulations to dismiss suits, which briefly ask the court to dismiss the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!